Clinical trial
Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS…
NCT00045539 · New Approaches to Brain Tumor Therapy Consortium, Other · Completed
Key facts
| NCT number | NCT00045539 |
|---|---|
| Title | Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
| Official title | A Phase II Study of Methotrexate and Thiotepa Chemotherapy for Patients With Newly Diagnosed Primary CNS Lymphoma |
| Lead sponsor | New Approaches to Brain Tumor Therapy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | leucovorin calcium, methotrexate, thiotepa |
| Start date | Oct 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: